# Lennar Corp: financial statements, quarterly

LEN · NYSE · CIK 920760 · [Industrials](/sectors/industrials.md) · fiscal year ends Nov 30

Pages: [Overview](/companies/len.md) · [Financials](/companies/len/financials.md) · [Filings](/companies/len/filings.md) · [Insiders](/companies/len/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/len/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [11.0 d](/filings/0001628280-26-003870.md) | [7.3](/filings/0001628280-25-016792.md) | [8.8](/filings/0001628280-25-033777.md) | [9.4](/filings/0001628280-25-044086.md) | [9.9 d](/filings/0001628280-26-003870.md) | [7.6](/filings/0001628280-26-024352.md) | [8.4](/filings/0001628280-26-046019.md) | [8.8](/filings/0001628280-26-064557.md) | [9.4 d](/filings/0001628280-26-003870.md) | [6.6](/filings/0001628280-26-024352.md) | [7.9](/filings/0001628280-26-046019.md) | [8.0](/filings/0001628280-26-064557.md) |
| Gross profit | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $bn | not reported | not reported | not reported | not reported | not reported | [0.6](/filings/0001628280-26-024352.md) | [0.7](/filings/0001628280-26-046019.md) | [0.7](/filings/0001628280-26-064557.md) | [0.7 d](/filings/0001628280-26-003870.md) | [0.6](/filings/0001628280-26-024352.md) | [0.7](/filings/0001628280-26-046019.md) | [0.7](/filings/0001628280-26-064557.md) |
| Operating income | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $bn | [0.4 d](/filings/0001628280-26-003870.md) | [0.2](/filings/0001628280-25-016792.md) | [0.3](/filings/0001628280-25-033777.md) | [0.3](/filings/0001628280-25-044086.md) | [0.4 d](/filings/0001628280-26-003870.md) | [0.2](/filings/0001628280-26-024352.md) | [0.2](/filings/0001628280-26-046019.md) | [0.2](/filings/0001628280-26-064557.md) | [0.2 d](/filings/0001628280-26-003870.md) | [0.1](/filings/0001628280-26-024352.md) | [0.1](/filings/0001628280-26-046019.md) | [0.1](/filings/0001628280-26-064557.md) |
| Net income | $bn | [1.4 d](/filings/0001628280-26-003870.md) | [0.7](/filings/0001628280-25-016792.md) | [1.0](/filings/0001628280-25-033777.md) | [1.2](/filings/0001628280-25-044086.md) | [1.1 d](/filings/0001628280-26-003870.md) | [0.5](/filings/0001628280-26-024352.md) | [0.5](/filings/0001628280-26-046019.md) | [0.6](/filings/0001628280-26-064557.md) | [0.5 d](/filings/0001628280-26-003870.md) | [0.2](/filings/0001628280-26-024352.md) | [0.3](/filings/0001628280-26-046019.md) | [0.3](/filings/0001628280-26-064557.md) |
| Diluted EPS | $ per share | not reported | [2.57](/filings/0001628280-25-016792.md) | [3.45](/filings/0001628280-25-033777.md) | [4.26](/filings/0001628280-25-044086.md) | not reported | [1.96](/filings/0001628280-26-024352.md) | [1.81](/filings/0001628280-26-046019.md) | [2.29](/filings/0001628280-26-064557.md) | not reported | [0.93](/filings/0001628280-26-024352.md) | [1.24](/filings/0001628280-26-046019.md) | [1.19](/filings/0001628280-26-064557.md) |
| Basic EPS | $ per share | not reported | [2.57](/filings/0001628280-25-016792.md) | [3.45](/filings/0001628280-25-033777.md) | [4.26](/filings/0001628280-25-044086.md) | not reported | [1.96](/filings/0001628280-26-024352.md) | [1.81](/filings/0001628280-26-046019.md) | [2.29](/filings/0001628280-26-064557.md) | not reported | [0.93](/filings/0001628280-26-024352.md) | [1.24](/filings/0001628280-26-046019.md) | [1.19](/filings/0001628280-26-064557.md) |

- Revenue: us-gaap:Revenues
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: not reported
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | [4.9](/filings/0001628280-26-003870.md) | not reported | not reported | not reported | [3.8](/filings/0001628280-26-003870.md) | not reported | not reported | not reported |
| Total assets | $bn | [39.2](/filings/0001628280-25-002404.md) | [39.0](/filings/0001628280-24-013820.md) | [38.7](/filings/0001628280-24-030508.md) | [39.7](/filings/0001628280-24-041915.md) | [41.3](/filings/0001628280-26-003870.md) | [35.0](/filings/0001628280-25-016792.md) | [34.4](/filings/0001628280-25-033777.md) | [34.9](/filings/0001628280-25-044086.md) | [34.4](/filings/0001628280-26-046019.md) | [33.2](/filings/0001628280-26-024352.md) | [33.7](/filings/0001628280-26-046019.md) | not reported |
| Total liabilities | $bn | [12.5](/filings/0001628280-25-002404.md) | [12.2](/filings/0001628280-24-013820.md) | [11.7](/filings/0001628280-24-030508.md) | [12.2](/filings/0001628280-24-041915.md) | [13.3](/filings/0001628280-26-003870.md) | [12.1](/filings/0001628280-25-016792.md) | [11.6](/filings/0001628280-25-033777.md) | [12.1](/filings/0001628280-25-044086.md) | [12.3](/filings/0001628280-26-046019.md) | [11.2](/filings/0001628280-26-024352.md) | [11.9](/filings/0001628280-26-046019.md) | not reported |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | [4.2](/filings/0001628280-26-003870.md) | not reported | not reported | not reported | [5.9](/filings/0001628280-26-003870.md) | not reported | not reported | not reported |
| Shareholders' equity | $bn | [26.6](/filings/0001628280-25-002404.md) | [26.6](/filings/0001628280-24-013820.md) | [26.9](/filings/0001628280-24-030508.md) | [27.4](/filings/0001628280-24-041915.md) | [27.9](/filings/0001628280-26-003870.md) | [22.7](/filings/0001628280-25-016792.md) | [22.6](/filings/0001628280-25-033777.md) | [22.6](/filings/0001628280-25-044086.md) | [22.0](/filings/0001628280-26-064557.md) | [21.9](/filings/0001628280-26-024352.md) | [21.6](/filings/0001628280-26-046019.md) | [21.6](/filings/0001628280-26-064557.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,589 d](/filings/0001628280-26-003870.md) | [368](/filings/0001628280-25-016792.md) | [242 d](/filings/0001628280-25-033777.md) | [819 d](/filings/0001628280-25-044086.md) | [975 d](/filings/0001628280-26-003870.md) | [(289)](/filings/0001628280-26-024352.md) | [(1,095) d](/filings/0001628280-26-046019.md) | [(159) d](/filings/0001628280-26-064557.md) | [1,759 d](/filings/0001628280-26-003870.md) | [(434)](/filings/0001628280-26-024352.md) | [(284) d](/filings/0001628280-26-046019.md) | [(104) d](/filings/0001628280-26-064557.md) |
| Capital expenditure | $m | [46.2 d](/filings/0001628280-26-003870.md) | [72.9](/filings/0001628280-25-016792.md) | [38.8 d](/filings/0001628280-25-033777.md) | [18.4 d](/filings/0001628280-25-044086.md) | [41.4 d](/filings/0001628280-26-003870.md) | [56.0](/filings/0001628280-26-024352.md) | [15.2 d](/filings/0001628280-26-046019.md) | [32.2 d](/filings/0001628280-26-064557.md) | [85.2 d](/filings/0001628280-26-003870.md) | [30.0](/filings/0001628280-26-024352.md) | [18.9 d](/filings/0001628280-26-046019.md) | [(8.0) d](/filings/0001628280-26-064557.md) |
| Dividends paid | $m | [105 d](/filings/0001628280-26-003870.md) | [139](/filings/0001628280-25-016792.md) | [139 d](/filings/0001628280-25-033777.md) | [136 d](/filings/0001628280-25-044086.md) | [135 d](/filings/0001628280-26-003870.md) | [132](/filings/0001628280-26-024352.md) | [134 d](/filings/0001628280-26-046019.md) | [129 d](/filings/0001628280-26-064557.md) | [127 d](/filings/0001628280-26-003870.md) | [123](/filings/0001628280-26-024352.md) | [123 d](/filings/0001628280-26-046019.md) | [119 d](/filings/0001628280-26-064557.md) |
| Share repurchases | $m | [341 d](/filings/0001628280-26-003870.md) | [595](/filings/0001628280-25-016792.md) | [610 d](/filings/0001628280-25-033777.md) | [525 d](/filings/0001628280-25-044086.md) | [527 d](/filings/0001628280-26-003870.md) | [774](/filings/0001628280-26-024352.md) | [521 d](/filings/0001628280-26-046019.md) | [512 d](/filings/0001628280-26-064557.md) | [0.1 d](/filings/0001628280-26-003870.md) | [270](/filings/0001628280-26-024352.md) | [467 d](/filings/0001628280-26-046019.md) | [256 d](/filings/0001628280-26-064557.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-02-28) | Q2 FY2023 (2023-05-31) | Q3 FY2023 (2023-08-31) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [286](/filings/0001628280-24-013820.md) | [285](/filings/0001628280-24-030508.md) | [283](/filings/0001628280-24-041915.md) | [277](/filings/0001628280-25-016792.md) | [274](/filings/0001628280-25-033777.md) | [270](/filings/0001628280-25-044086.md) | [263](/filings/0001628280-26-024352.md) | [260](/filings/0001628280-26-046019.md) | [256](/filings/0001628280-26-064557.md) | [244](/filings/0001628280-26-024352.md) | [241](/filings/0001628280-26-046019.md) | [238](/filings/0001628280-26-064557.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.